Pyxis Oncology (PYXS) Other Non Operating Income (2021)
Pyxis Oncology's (PYXS) quarterly Other Non Operating Income came in at -$410000.0 in Q4 2021, up 83.98% on a QoQ basis from -$2.6 million in Q3 2021.
Pyxis Oncology (PYXS) Other Non Operating Income (2021) Analysis & Trends
Pyxis Oncology (PYXS) has 1 years of Other Non Operating Income data on file, last reported at -$410000.0 in Q4 2021.
- On a quarterly basis, Other Non Operating Income changed N/A year-over-year to -$410000.0 in Q4 2021; TTM through Dec 2021 was -$6.2 million, a N/A change from a year earlier, with the FY2021 full-year figure at -$6.2 million, changed N/A from the prior year.
- Other Non Operating Income for Q4 2021 stood at -$410000.0, up from -$2.6 million in the prior quarter.
- Over the last five years, Other Non Operating Income for PYXS reached as high as -$410000.0 in Q4 2021 and fell as low as -$2.6 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Pyxis Oncology | 166.54 Mn | 99.69 Mn | 8.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -410,000.00 |
| Sep 30, 2021 | -2.56 Mn |
| Jun 30, 2021 | -2.16 Mn |
| Mar 31, 2021 | -1.10 Mn |